Clinical Trial Update: A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/II trial evaluating safety and efficacy of QL1706 in patients with advanced hepatocellular carcinoma is ongoing and status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Drugs mentioned

• QL1706

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Advanced Liver Cancer | Phase 1, Phase 2 | Status: UNKNOWN